Bristol Myers Stock Forecast - Daily Balance Of Power

<div class='circular--portrait' style='background:#689CFD;color: #ffffff;font-size:4em;padding-top: 25px;;'>BM</div>
BMY -- USA Stock  

Report: 6th of August 2020  

Bristol Myers Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Bristol Myers historical stock prices and determine the direction of Bristol Myers Squibb's future trends based on various well-known forecasting models. However, solely looking at the historical price movement is usually misleading. Macroaxis recommends to always use this module together with analysis of Bristol Myers historical fundamentals such as revenue growth or operating cash flow patterns. Although Bristol Myers naive historical forecasting may sometimes provide an important future outlook for the firm we recommend to always cross-verify it against solid analysis of Bristol Myers Squibb systematic risk associated with finding meaningful patterns of Bristol Myers fundamentals over time. Continue to Historical Fundamental Analysis of Bristol Myers to cross-verify your projections.

Search Stock Forecast

 
Refresh
Bristol Myers Receivables Turnover is fairly stable at the moment as compared to the past year. Bristol Myers reported Receivables Turnover of 4.01 in 2019. Inventory Turnover is likely to grow to 3.12 in 2020, whereas PPandE Turnover is likely to drop 4.13 in 2020. . Weighted Average Shares Diluted is likely to grow to about 1.9 B in 2020, whereas Weighted Average Shares is likely to drop slightly above 1.6 B in 2020.
Bristol Myers Squibb has current Daily Balance Of Power of (0.73). Balance of Power indicator (or BOP) measures the strength of Bristol Myers Squibb market sensitivity to bulls and bears. It estimates the ability of Bristol Myers buyers and sellers to push price to an extreme high or extreme low level. As a result, by monitoring Bristol Myers Balance of Power indicator one can determine a trend of the price direction.
  Previous Daily Balance Of PowerDaily Balance Of PowerTrend
(0.67)(0.73)
Check Bristol Myers Volatility | Backtest Bristol Myers | Information Ratio  

Bristol Myers Trading Date Momentum

On July 10 2020 Bristol Myers Squibb was traded for  57.43  at the closing time. Highest Bristol Myers's price during the trading hours was 58.09  and the lowest price during the day was  57.16 . The net volume was 8.3 M. The overall trading history on the 10th of July did not affect price variability. The overall trading delta to current price is 0.99% .
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare Bristol Myers to competition

Other Forecasting Options for Bristol Myers

View Currently Related Equities

Bristol Myers Squibb Technical and Predictive Analytics

Bristol Myers Market Strength Events

Volatility Measures

Bristol Myers Risk Indicators

Did you try this?

Run Probability Of Bankruptcy Now

   

Probability Of Bankruptcy

Get analysis of equity chance of financial distress in the next 2 years
All  Next Launch Module

Bristol Myers Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Bristol Myers and Gilead Sciences. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to Historical Fundamental Analysis of Bristol Myers to cross-verify your projections. Please also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page